

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.09123506 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.64156600 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 5.63988778 |
| 4 | vocalization behavior (GO:0071625) | 5.56716480 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 5.41542369 |
| 6 | locomotory exploration behavior (GO:0035641) | 5.34265121 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.33046301 |
| 8 | glutamate secretion (GO:0014047) | 5.30670170 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.27066292 |
| 10 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.17270613 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.01505188 |
| 12 | protein localization to synapse (GO:0035418) | 4.92637456 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.87061879 |
| 14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.61095144 |
| 15 | exploration behavior (GO:0035640) | 4.60362482 |
| 16 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.58843026 |
| 17 | nucleobase catabolic process (GO:0046113) | 4.54813378 |
| 18 | neurotransmitter secretion (GO:0007269) | 4.53643665 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 4.49864124 |
| 20 | establishment of mitochondrion localization (GO:0051654) | 4.40511735 |
| 21 | layer formation in cerebral cortex (GO:0021819) | 4.38481877 |
| 22 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.21404813 |
| 23 | regulation of synapse structural plasticity (GO:0051823) | 4.20948807 |
| 24 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.20693318 |
| 25 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.20380336 |
| 26 | neuron recognition (GO:0008038) | 4.15492028 |
| 27 | glutamate receptor signaling pathway (GO:0007215) | 4.14312389 |
| 28 | synaptic transmission, glutamatergic (GO:0035249) | 4.10183210 |
| 29 | neuronal action potential propagation (GO:0019227) | 4.09887885 |
| 30 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.98021687 |
| 31 | neuron-neuron synaptic transmission (GO:0007270) | 3.96768999 |
| 32 | positive regulation of synapse maturation (GO:0090129) | 3.90687316 |
| 33 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.84204536 |
| 34 | dendritic spine morphogenesis (GO:0060997) | 3.81783777 |
| 35 | axonal fasciculation (GO:0007413) | 3.81761489 |
| 36 | proline transport (GO:0015824) | 3.77997211 |
| 37 | postsynaptic membrane organization (GO:0001941) | 3.72013723 |
| 38 | gamma-aminobutyric acid transport (GO:0015812) | 3.71529919 |
| 39 | neuronal ion channel clustering (GO:0045161) | 3.67871705 |
| 40 | neurotransmitter transport (GO:0006836) | 3.66554649 |
| 41 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.65277499 |
| 42 | long-term memory (GO:0007616) | 3.56772720 |
| 43 | synaptic vesicle endocytosis (GO:0048488) | 3.56073910 |
| 44 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.55994201 |
| 45 | positive regulation of membrane potential (GO:0045838) | 3.54757945 |
| 46 | regulation of postsynaptic membrane potential (GO:0060078) | 3.53708643 |
| 47 | positive regulation of synapse assembly (GO:0051965) | 3.50788972 |
| 48 | sodium ion export (GO:0071436) | 3.50593762 |
| 49 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.49713316 |
| 50 | positive regulation of dendritic spine development (GO:0060999) | 3.49080737 |
| 51 | regulation of neurotransmitter levels (GO:0001505) | 3.46149458 |
| 52 | activation of protein kinase A activity (GO:0034199) | 3.44986299 |
| 53 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.42447579 |
| 54 | regulation of neurotransmitter secretion (GO:0046928) | 3.41830027 |
| 55 | dendrite morphogenesis (GO:0048813) | 3.41158586 |
| 56 | regulation of synaptic plasticity (GO:0048167) | 3.41083129 |
| 57 | regulation of vesicle fusion (GO:0031338) | 3.40325170 |
| 58 | neurofilament cytoskeleton organization (GO:0060052) | 3.38949510 |
| 59 | presynaptic membrane assembly (GO:0097105) | 3.37840674 |
| 60 | transmission of nerve impulse (GO:0019226) | 3.37742554 |
| 61 | cell migration in hindbrain (GO:0021535) | 3.36857248 |
| 62 | auditory behavior (GO:0031223) | 3.36666716 |
| 63 | long-term synaptic potentiation (GO:0060291) | 3.35378251 |
| 64 | cellular potassium ion homeostasis (GO:0030007) | 3.34660803 |
| 65 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.34197862 |
| 66 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.34047235 |
| 67 | mitochondrion transport along microtubule (GO:0047497) | 3.34047235 |
| 68 | glycosphingolipid biosynthetic process (GO:0006688) | 3.32746356 |
| 69 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.31687696 |
| 70 | synapse assembly (GO:0007416) | 3.28180174 |
| 71 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.27562288 |
| 72 | negative regulation of microtubule polymerization (GO:0031115) | 3.26546923 |
| 73 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.25517959 |
| 74 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.24467495 |
| 75 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.24346672 |
| 76 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.23417758 |
| 77 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.21967681 |
| 78 | response to auditory stimulus (GO:0010996) | 3.20616098 |
| 79 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.20139407 |
| 80 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.19178244 |
| 81 | neuromuscular synaptic transmission (GO:0007274) | 3.18494332 |
| 82 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.18274854 |
| 83 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.17769949 |
| 84 | regulation of neurotransmitter transport (GO:0051588) | 3.17742171 |
| 85 | innervation (GO:0060384) | 3.16896137 |
| 86 | presynaptic membrane organization (GO:0097090) | 3.16316189 |
| 87 | synaptic vesicle transport (GO:0048489) | 3.15611170 |
| 88 | positive regulation of neurotransmitter transport (GO:0051590) | 3.15161739 |
| 89 | prepulse inhibition (GO:0060134) | 3.13986150 |
| 90 | response to histamine (GO:0034776) | 3.12333734 |
| 91 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.12154436 |
| 92 | dendritic spine organization (GO:0097061) | 3.11566899 |
| 93 | regulation of dendritic spine development (GO:0060998) | 3.11285787 |
| 94 | regulation of synapse maturation (GO:0090128) | 3.10545642 |
| 95 | regulation of glutamate secretion (GO:0014048) | 3.09518086 |
| 96 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.09254020 |
| 97 | behavioral fear response (GO:0001662) | 3.09089521 |
| 98 | behavioral defense response (GO:0002209) | 3.09089521 |
| 99 | mating behavior (GO:0007617) | 3.08936573 |
| 100 | membrane depolarization (GO:0051899) | 3.08817634 |
| 101 | learning (GO:0007612) | 3.06852232 |
| 102 | cerebellar granule cell differentiation (GO:0021707) | 3.06690062 |
| 103 | neuromuscular process controlling balance (GO:0050885) | 3.05524103 |
| 104 | neuromuscular process controlling posture (GO:0050884) | 3.04223815 |
| 105 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.03958775 |
| 106 | adult walking behavior (GO:0007628) | 3.03783190 |
| 107 | cell communication by electrical coupling (GO:0010644) | 3.03243204 |
| 108 | cerebellar Purkinje cell layer development (GO:0021680) | 3.02537641 |
| 109 | intraspecies interaction between organisms (GO:0051703) | 3.01073743 |
| 110 | social behavior (GO:0035176) | 3.01073743 |
| 111 | membrane hyperpolarization (GO:0060081) | 3.00757630 |
| 112 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.00571525 |
| 113 | acidic amino acid transport (GO:0015800) | 3.00156393 |
| 114 | mechanosensory behavior (GO:0007638) | 3.00144161 |
| 115 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.99932401 |
| 116 | membrane depolarization during action potential (GO:0086010) | 2.99127135 |
| 117 | synaptic transmission (GO:0007268) | 2.99056250 |
| 118 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.98928691 |
| 119 | fear response (GO:0042596) | 2.98279343 |
| 120 | response to pheromone (GO:0019236) | 2.98128688 |
| 121 | establishment of synaptic vesicle localization (GO:0097480) | 2.98085189 |
| 122 | synapse organization (GO:0050808) | 2.96657511 |
| 123 | regulation of synapse assembly (GO:0051963) | 2.94886781 |
| 124 | L-amino acid import (GO:0043092) | 2.93593000 |
| 125 | organelle transport along microtubule (GO:0072384) | 2.92624025 |
| 126 | establishment of vesicle localization (GO:0051650) | 2.91240532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.75188730 |
| 2 | * GBX2_23144817_ChIP-Seq_PC3_Human | 3.50078289 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.18070843 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.11159518 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.04449656 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.84615763 |
| 7 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.69896172 |
| 8 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.69896172 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.68122722 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.65308587 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.61973760 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.57985003 |
| 13 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.57591305 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.52227346 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.51635502 |
| 16 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.48019567 |
| 17 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.42340449 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.31747476 |
| 19 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.31408776 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.31183413 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.30507482 |
| 22 | * NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.29395434 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.28568347 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.18753861 |
| 25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.11717517 |
| 26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.10820386 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.04405629 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.93108111 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.90399076 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.89902259 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.84626935 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.77958914 |
| 33 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.66944682 |
| 34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.62704371 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.61460517 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.60226795 |
| 37 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.54954777 |
| 38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.54570737 |
| 39 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.51421402 |
| 40 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.46790515 |
| 41 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.45011818 |
| 42 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.43605362 |
| 43 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.41691024 |
| 44 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.39734367 |
| 45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37801917 |
| 46 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.35751180 |
| 47 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.34269110 |
| 48 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33184374 |
| 49 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32790012 |
| 50 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30376965 |
| 51 | AR_25329375_ChIP-Seq_VCAP_Human | 1.28847933 |
| 52 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.28828677 |
| 53 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.27888335 |
| 54 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27446375 |
| 55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.27101400 |
| 56 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17454711 |
| 57 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.16583931 |
| 58 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.16576296 |
| 59 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16380871 |
| 60 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.15751594 |
| 61 | STAT3_23295773_ChIP-Seq_U87_Human | 1.15741488 |
| 62 | AR_19668381_ChIP-Seq_PC3_Human | 1.15646781 |
| 63 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14328657 |
| 64 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12908640 |
| 65 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.12323482 |
| 66 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.11343336 |
| 67 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07299863 |
| 68 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.06730588 |
| 69 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.05256408 |
| 70 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.05027309 |
| 71 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03918938 |
| 72 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03308515 |
| 73 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.03104058 |
| 74 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02476354 |
| 75 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01637673 |
| 76 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00997733 |
| 77 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00478467 |
| 78 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.00460453 |
| 79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99736024 |
| 80 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99500729 |
| 81 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99500729 |
| 82 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.98993192 |
| 83 | JUN_21703547_ChIP-Seq_K562_Human | 0.98954475 |
| 84 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98675742 |
| 85 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98307668 |
| 86 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.95325926 |
| 87 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95143537 |
| 88 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.95070056 |
| 89 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.95070056 |
| 90 | FUS_26573619_Chip-Seq_HEK293_Human | 0.94878162 |
| 91 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94840318 |
| 92 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.94569928 |
| 93 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.94238152 |
| 94 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94230049 |
| 95 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.93917036 |
| 96 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93305394 |
| 97 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.93267565 |
| 98 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.92609566 |
| 99 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.92362959 |
| 100 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.91990867 |
| 101 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.91721450 |
| 102 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.91110155 |
| 103 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90296021 |
| 104 | KDM2B_26808549_Chip-Seq_K562_Human | 0.90071920 |
| 105 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89696463 |
| 106 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.89625263 |
| 107 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.88129848 |
| 108 | KDM2B_26808549_Chip-Seq_REH_Human | 0.85670580 |
| 109 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.85604573 |
| 110 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.84975663 |
| 111 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.84907691 |
| 112 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.83214115 |
| 113 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82768470 |
| 114 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.82742079 |
| 115 | VDR_22108803_ChIP-Seq_LS180_Human | 0.82577540 |
| 116 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.81939547 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.09144258 |
| 2 | MP0003880_abnormal_central_pattern | 5.02662090 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.08864612 |
| 4 | MP0004270_analgesia | 3.62390853 |
| 5 | MP0009745_abnormal_behavioral_response | 3.35221329 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.33590241 |
| 7 | MP0005423_abnormal_somatic_nervous | 3.18202564 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.07729329 |
| 9 | MP0002064_seizures | 3.05647712 |
| 10 | MP0009046_muscle_twitch | 2.92920964 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.84570021 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.66268552 |
| 13 | MP0002822_catalepsy | 2.65815452 |
| 14 | MP0006276_abnormal_autonomic_nervous | 2.55379757 |
| 15 | MP0002272_abnormal_nervous_system | 2.46124465 |
| 16 | MP0002735_abnormal_chemical_nociception | 2.43082439 |
| 17 | MP0001486_abnormal_startle_reflex | 2.41601092 |
| 18 | MP0002736_abnormal_nociception_after | 2.38578645 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.35462981 |
| 20 | MP0002733_abnormal_thermal_nociception | 2.26656254 |
| 21 | MP0001501_abnormal_sleep_pattern | 2.21905058 |
| 22 | MP0000778_abnormal_nervous_system | 2.13161039 |
| 23 | MP0002184_abnormal_innervation | 2.09512993 |
| 24 | MP0001970_abnormal_pain_threshold | 2.05830416 |
| 25 | MP0002067_abnormal_sensory_capabilities | 2.01191593 |
| 26 | MP0001984_abnormal_olfaction | 1.95456539 |
| 27 | MP0002557_abnormal_social/conspecific_i | 1.90606144 |
| 28 | MP0004924_abnormal_behavior | 1.86620569 |
| 29 | MP0005386_behavior/neurological_phenoty | 1.86620569 |
| 30 | MP0003122_maternal_imprinting | 1.83766868 |
| 31 | MP0004811_abnormal_neuron_physiology | 1.81955757 |
| 32 | MP0004858_abnormal_nervous_system | 1.80721465 |
| 33 | MP0003329_amyloid_beta_deposits | 1.78746018 |
| 34 | MP0001529_abnormal_vocalization | 1.75300090 |
| 35 | MP0001905_abnormal_dopamine_level | 1.70082268 |
| 36 | MP0005645_abnormal_hypothalamus_physiol | 1.66396137 |
| 37 | MP0008569_lethality_at_weaning | 1.64290860 |
| 38 | MP0002909_abnormal_adrenal_gland | 1.63524516 |
| 39 | MP0000955_abnormal_spinal_cord | 1.60156629 |
| 40 | MP0009780_abnormal_chondrocyte_physiolo | 1.55085780 |
| 41 | MP0005646_abnormal_pituitary_gland | 1.52877300 |
| 42 | MP0003787_abnormal_imprinting | 1.52572950 |
| 43 | MP0002882_abnormal_neuron_morphology | 1.47322017 |
| 44 | MP0003879_abnormal_hair_cell | 1.45394365 |
| 45 | MP0002066_abnormal_motor_capabilities/c | 1.42937561 |
| 46 | MP0004142_abnormal_muscle_tone | 1.38915935 |
| 47 | MP0001188_hyperpigmentation | 1.35466146 |
| 48 | MP0001502_abnormal_circadian_rhythm | 1.32344655 |
| 49 | MP0001986_abnormal_taste_sensitivity | 1.30666471 |
| 50 | MP0002102_abnormal_ear_morphology | 1.27275321 |
| 51 | MP0004885_abnormal_endolymph | 1.22885017 |
| 52 | MP0000569_abnormal_digit_pigmentation | 1.18226572 |
| 53 | MP0002152_abnormal_brain_morphology | 1.17655246 |
| 54 | MP0008877_abnormal_DNA_methylation | 1.16096202 |
| 55 | MP0003633_abnormal_nervous_system | 1.12749139 |
| 56 | MP0010386_abnormal_urinary_bladder | 1.07026147 |
| 57 | MP0000751_myopathy | 1.05293537 |
| 58 | MP0003631_nervous_system_phenotype | 1.02331573 |
| 59 | MP0003690_abnormal_glial_cell | 1.01370086 |
| 60 | MP0008872_abnormal_physiological_respon | 1.01309614 |
| 61 | MP0004742_abnormal_vestibular_system | 0.99670212 |
| 62 | MP0002069_abnormal_eating/drinking_beha | 0.97708231 |
| 63 | MP0005499_abnormal_olfactory_system | 0.96647731 |
| 64 | MP0005394_taste/olfaction_phenotype | 0.96647731 |
| 65 | MP0002229_neurodegeneration | 0.90954401 |
| 66 | MP0000920_abnormal_myelination | 0.88563331 |
| 67 | MP0002638_abnormal_pupillary_reflex | 0.88522815 |
| 68 | MP0002653_abnormal_ependyma_morphology | 0.87575413 |
| 69 | MP0000631_abnormal_neuroendocrine_gland | 0.87505406 |
| 70 | MP0002752_abnormal_somatic_nervous | 0.85400185 |
| 71 | MP0005535_abnormal_body_temperature | 0.85093833 |
| 72 | MP0004145_abnormal_muscle_electrophysio | 0.83040395 |
| 73 | MP0005551_abnormal_eye_electrophysiolog | 0.82919824 |
| 74 | MP0001963_abnormal_hearing_physiology | 0.80596625 |
| 75 | MP0008874_decreased_physiological_sensi | 0.78834352 |
| 76 | MP0004085_abnormal_heartbeat | 0.78465537 |
| 77 | MP0001177_atelectasis | 0.77857730 |
| 78 | MP0003634_abnormal_glial_cell | 0.77177236 |
| 79 | MP0002837_dystrophic_cardiac_calcinosis | 0.77010088 |
| 80 | MP0003632_abnormal_nervous_system | 0.76144475 |
| 81 | MP0000604_amyloidosis | 0.74808488 |
| 82 | MP0003123_paternal_imprinting | 0.74647896 |
| 83 | MP0008961_abnormal_basal_metabolism | 0.73248877 |
| 84 | MP0004147_increased_porphyrin_level | 0.71385391 |
| 85 | MP0003938_abnormal_ear_development | 0.70923356 |
| 86 | MP0004133_heterotaxia | 0.69924111 |
| 87 | MP0003121_genomic_imprinting | 0.69497318 |
| 88 | MP0003861_abnormal_nervous_system | 0.69129056 |
| 89 | MP0001664_abnormal_digestion | 0.67844636 |
| 90 | MP0002876_abnormal_thyroid_physiology | 0.65080779 |
| 91 | MP0005253_abnormal_eye_physiology | 0.64211464 |
| 92 | MP0005409_darkened_coat_color | 0.63399248 |
| 93 | MP0003137_abnormal_impulse_conducting | 0.62201037 |
| 94 | MP0002751_abnormal_autonomic_nervous | 0.61712342 |
| 95 | MP0008789_abnormal_olfactory_epithelium | 0.59442868 |
| 96 | MP0000013_abnormal_adipose_tissue | 0.59264075 |
| 97 | MP0004215_abnormal_myocardial_fiber | 0.58740371 |
| 98 | MP0001943_abnormal_respiration | 0.58239067 |
| 99 | MP0002082_postnatal_lethality | 0.55606436 |
| 100 | MP0010770_preweaning_lethality | 0.55606436 |
| 101 | MP0010769_abnormal_survival | 0.55515976 |
| 102 | MP0001299_abnormal_eye_distance/ | 0.54460961 |
| 103 | MP0001485_abnormal_pinna_reflex | 0.54188796 |
| 104 | MP0002090_abnormal_vision | 0.53941989 |
| 105 | MP0004233_abnormal_muscle_weight | 0.52323457 |
| 106 | MP0010768_mortality/aging | 0.52249347 |
| 107 | MP0004043_abnormal_pH_regulation | 0.52199765 |
| 108 | MP0005187_abnormal_penis_morphology | 0.51539834 |
| 109 | MP0003956_abnormal_body_size | 0.51536616 |
| 110 | MP0000026_abnormal_inner_ear | 0.51495444 |
| 111 | MP0002234_abnormal_pharynx_morphology | 0.50909168 |
| 112 | MP0003183_abnormal_peptide_metabolism | 0.50099346 |
| 113 | MP0004484_altered_response_of | 0.49887604 |
| 114 | MP0005623_abnormal_meninges_morphology | 0.48431668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.41212276 |
| 2 | Myokymia (HP:0002411) | 6.74695347 |
| 3 | Focal seizures (HP:0007359) | 5.73232556 |
| 4 | Visual hallucinations (HP:0002367) | 5.33217744 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.74477043 |
| 6 | Atonic seizures (HP:0010819) | 4.50197192 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.39148940 |
| 8 | Febrile seizures (HP:0002373) | 4.36615173 |
| 9 | Absence seizures (HP:0002121) | 4.13981080 |
| 10 | Limb dystonia (HP:0002451) | 3.91313215 |
| 11 | Dialeptic seizures (HP:0011146) | 3.76346625 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.73938931 |
| 13 | Supranuclear gaze palsy (HP:0000605) | 3.63281606 |
| 14 | Action tremor (HP:0002345) | 3.51520090 |
| 15 | Broad-based gait (HP:0002136) | 3.48604209 |
| 16 | Ankle clonus (HP:0011448) | 3.37250000 |
| 17 | Hyperventilation (HP:0002883) | 3.36782140 |
| 18 | Mutism (HP:0002300) | 3.35745381 |
| 19 | Poor eye contact (HP:0000817) | 3.23688650 |
| 20 | Abnormal eating behavior (HP:0100738) | 3.14197505 |
| 21 | Amblyopia (HP:0000646) | 3.12784799 |
| 22 | Polyphagia (HP:0002591) | 3.12027831 |
| 23 | Depression (HP:0000716) | 3.11656689 |
| 24 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.04663742 |
| 25 | Drooling (HP:0002307) | 2.93404999 |
| 26 | Excessive salivation (HP:0003781) | 2.93404999 |
| 27 | Anxiety (HP:0000739) | 2.91747784 |
| 28 | Abnormal social behavior (HP:0012433) | 2.91375574 |
| 29 | Impaired social interactions (HP:0000735) | 2.91375574 |
| 30 | Gaze-evoked nystagmus (HP:0000640) | 2.88587439 |
| 31 | Truncal ataxia (HP:0002078) | 2.86189800 |
| 32 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.85758618 |
| 33 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.85758618 |
| 34 | Progressive inability to walk (HP:0002505) | 2.82859958 |
| 35 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.81880786 |
| 36 | Pheochromocytoma (HP:0002666) | 2.77568534 |
| 37 | Papilledema (HP:0001085) | 2.77513610 |
| 38 | Failure to thrive in infancy (HP:0001531) | 2.75035116 |
| 39 | Dysdiadochokinesis (HP:0002075) | 2.74829485 |
| 40 | Dysmetria (HP:0001310) | 2.72750180 |
| 41 | Abnormality of the lower motor neuron (HP:0002366) | 2.71184243 |
| 42 | Torticollis (HP:0000473) | 2.63801964 |
| 43 | Genetic anticipation (HP:0003743) | 2.63368464 |
| 44 | Spastic tetraplegia (HP:0002510) | 2.62297167 |
| 45 | Peripheral hypomyelination (HP:0007182) | 2.62138560 |
| 46 | Cerebral hypomyelination (HP:0006808) | 2.61394006 |
| 47 | Cerebral inclusion bodies (HP:0100314) | 2.60677711 |
| 48 | Urinary urgency (HP:0000012) | 2.59931165 |
| 49 | Postural instability (HP:0002172) | 2.56593062 |
| 50 | Epileptiform EEG discharges (HP:0011182) | 2.55514798 |
| 51 | Cortical dysplasia (HP:0002539) | 2.53540149 |
| 52 | Spastic gait (HP:0002064) | 2.50631120 |
| 53 | Abnormality of the corticospinal tract (HP:0002492) | 2.50331643 |
| 54 | Amyotrophic lateral sclerosis (HP:0007354) | 2.48626254 |
| 55 | Agitation (HP:0000713) | 2.47997439 |
| 56 | Focal dystonia (HP:0004373) | 2.47991699 |
| 57 | EEG with generalized epileptiform discharges (HP:0011198) | 2.45011587 |
| 58 | Neuroendocrine neoplasm (HP:0100634) | 2.43859307 |
| 59 | Fetal akinesia sequence (HP:0001989) | 2.42231288 |
| 60 | Neurofibrillary tangles (HP:0002185) | 2.41684199 |
| 61 | Hemiparesis (HP:0001269) | 2.41417610 |
| 62 | Inability to walk (HP:0002540) | 2.36484421 |
| 63 | Bradykinesia (HP:0002067) | 2.36337165 |
| 64 | Split foot (HP:0001839) | 2.36177643 |
| 65 | Insidious onset (HP:0003587) | 2.35705965 |
| 66 | Termporal pattern (HP:0011008) | 2.35705965 |
| 67 | Hypsarrhythmia (HP:0002521) | 2.32691857 |
| 68 | Abnormality of binocular vision (HP:0011514) | 2.31101913 |
| 69 | Diplopia (HP:0000651) | 2.31101913 |
| 70 | Stereotypic behavior (HP:0000733) | 2.30910706 |
| 71 | Absent speech (HP:0001344) | 2.27765126 |
| 72 | Impaired smooth pursuit (HP:0007772) | 2.26377676 |
| 73 | Clonus (HP:0002169) | 2.24468852 |
| 74 | Craniofacial dystonia (HP:0012179) | 2.22293704 |
| 75 | Scanning speech (HP:0002168) | 2.20405746 |
| 76 | Hypoventilation (HP:0002791) | 2.20170600 |
| 77 | Sleep apnea (HP:0010535) | 2.17299202 |
| 78 | Akinesia (HP:0002304) | 2.14811498 |
| 79 | Pachygyria (HP:0001302) | 2.14421061 |
| 80 | Neuronal loss in central nervous system (HP:0002529) | 2.14020929 |
| 81 | Lower limb muscle weakness (HP:0007340) | 2.13704621 |
| 82 | Hypoplasia of the corpus callosum (HP:0002079) | 2.13161229 |
| 83 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.10355105 |
| 84 | Hypoplasia of the brainstem (HP:0002365) | 2.10355105 |
| 85 | Gait imbalance (HP:0002141) | 2.10055538 |
| 86 | Specific learning disability (HP:0001328) | 2.07192253 |
| 87 | Abnormal hair whorl (HP:0010721) | 2.05058153 |
| 88 | Status epilepticus (HP:0002133) | 2.04913034 |
| 89 | Congenital primary aphakia (HP:0007707) | 2.04294075 |
| 90 | Muscular hypotonia of the trunk (HP:0008936) | 2.03872778 |
| 91 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.03719830 |
| 92 | Abnormality of the labia minora (HP:0012880) | 2.02221677 |
| 93 | Poor suck (HP:0002033) | 1.98690888 |
| 94 | Nephrogenic diabetes insipidus (HP:0009806) | 1.98621123 |
| 95 | Ulnar claw (HP:0001178) | 1.98610955 |
| 96 | Apathy (HP:0000741) | 1.98509120 |
| 97 | Medial flaring of the eyebrow (HP:0010747) | 1.97834736 |
| 98 | Hemiplegia (HP:0002301) | 1.96192106 |
| 99 | Psychosis (HP:0000709) | 1.94913422 |
| 100 | Generalized myoclonic seizures (HP:0002123) | 1.94693075 |
| 101 | Intention tremor (HP:0002080) | 1.94139002 |
| 102 | CNS hypomyelination (HP:0003429) | 1.93662209 |
| 103 | Megalencephaly (HP:0001355) | 1.93042843 |
| 104 | Abnormality of salivation (HP:0100755) | 1.92763817 |
| 105 | Incomplete penetrance (HP:0003829) | 1.92223592 |
| 106 | Delusions (HP:0000746) | 1.91736470 |
| 107 | Impaired vibratory sensation (HP:0002495) | 1.90926559 |
| 108 | Protruding tongue (HP:0010808) | 1.90259447 |
| 109 | Diminished motivation (HP:0000745) | 1.89932664 |
| 110 | Paraplegia (HP:0010550) | 1.89807988 |
| 111 | Esotropia (HP:0000565) | 1.89215713 |
| 112 | Intellectual disability, severe (HP:0010864) | 1.89080222 |
| 113 | Lissencephaly (HP:0001339) | 1.89073827 |
| 114 | Ventricular fibrillation (HP:0001663) | 1.86624483 |
| 115 | Obstructive sleep apnea (HP:0002870) | 1.85482185 |
| 116 | Blue irides (HP:0000635) | 1.82400356 |
| 117 | Gait ataxia (HP:0002066) | 1.82309743 |
| 118 | Inappropriate behavior (HP:0000719) | 1.81002636 |
| 119 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.78750685 |
| 120 | Hyperthyroidism (HP:0000836) | 1.77767984 |
| 121 | Retinal dysplasia (HP:0007973) | 1.75826726 |
| 122 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.75466414 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.28116101 |
| 2 | MARK1 | 4.10825686 |
| 3 | MAP3K9 | 3.75339512 |
| 4 | EPHA4 | 3.66639175 |
| 5 | MAP3K4 | 2.99902829 |
| 6 | MINK1 | 2.90614009 |
| 7 | MAP3K12 | 2.68307973 |
| 8 | MAP2K7 | 2.64231174 |
| 9 | CASK | 2.43443553 |
| 10 | DAPK2 | 2.34991128 |
| 11 | NTRK2 | 2.29746589 |
| 12 | PAK6 | 2.01371116 |
| 13 | MAP2K4 | 1.98749788 |
| 14 | KSR1 | 1.89478890 |
| 15 | KSR2 | 1.86763401 |
| 16 | MAPK13 | 1.76553548 |
| 17 | PNCK | 1.66185676 |
| 18 | PLK2 | 1.66171858 |
| 19 | NTRK1 | 1.62419041 |
| 20 | DAPK1 | 1.59702815 |
| 21 | ARAF | 1.55968663 |
| 22 | GRK5 | 1.52810226 |
| 23 | CDK5 | 1.52162725 |
| 24 | SIK2 | 1.48734729 |
| 25 | CAMKK1 | 1.46687480 |
| 26 | MAP4K2 | 1.45409325 |
| 27 | TRIM28 | 1.44052160 |
| 28 | RIPK4 | 1.42213464 |
| 29 | TNIK | 1.42065794 |
| 30 | CDK19 | 1.40373767 |
| 31 | UHMK1 | 1.28301501 |
| 32 | PRKCG | 1.27108321 |
| 33 | PHKG2 | 1.26340427 |
| 34 | PHKG1 | 1.26340427 |
| 35 | PRPF4B | 1.23205865 |
| 36 | SIK3 | 1.21013842 |
| 37 | CSNK1A1L | 1.13685153 |
| 38 | LATS2 | 1.12799629 |
| 39 | PRKD3 | 1.10872424 |
| 40 | CAMKK2 | 1.07556356 |
| 41 | CSNK1G2 | 1.06438412 |
| 42 | CDK18 | 1.05945879 |
| 43 | TYRO3 | 1.04672779 |
| 44 | CAMK2A | 1.04221316 |
| 45 | CDK14 | 1.00163168 |
| 46 | CDK15 | 0.99384285 |
| 47 | FES | 0.95052873 |
| 48 | CSNK1G1 | 0.90812012 |
| 49 | MAP3K2 | 0.90520337 |
| 50 | SGK223 | 0.89869925 |
| 51 | SGK494 | 0.89869925 |
| 52 | CDK11A | 0.87022442 |
| 53 | STK38 | 0.86601396 |
| 54 | PAK3 | 0.86077260 |
| 55 | TESK1 | 0.85203649 |
| 56 | CAMK2B | 0.85156591 |
| 57 | MAP3K13 | 0.81118983 |
| 58 | RET | 0.80702487 |
| 59 | PKN1 | 0.80630502 |
| 60 | EPHA3 | 0.80541636 |
| 61 | DYRK1A | 0.79407251 |
| 62 | BCR | 0.75573436 |
| 63 | CAMK1 | 0.74593719 |
| 64 | SGK2 | 0.74126541 |
| 65 | STK11 | 0.70616503 |
| 66 | RAF1 | 0.70225277 |
| 67 | PTK2B | 0.70109992 |
| 68 | OXSR1 | 0.68456997 |
| 69 | TAOK1 | 0.67864436 |
| 70 | MARK2 | 0.67718658 |
| 71 | ERBB3 | 0.64210358 |
| 72 | CSNK1G3 | 0.62450262 |
| 73 | DYRK2 | 0.61766716 |
| 74 | PRKCH | 0.60594392 |
| 75 | LMTK2 | 0.60291521 |
| 76 | BMPR2 | 0.60137650 |
| 77 | PRKCZ | 0.57458801 |
| 78 | SGK1 | 0.57378575 |
| 79 | CCNB1 | 0.56692519 |
| 80 | NME1 | 0.55224543 |
| 81 | DYRK1B | 0.51140584 |
| 82 | PRKCE | 0.51132211 |
| 83 | WNK3 | 0.51128582 |
| 84 | CAMK1G | 0.50798099 |
| 85 | SGK3 | 0.50657151 |
| 86 | RPS6KA2 | 0.50653746 |
| 87 | CAMK2G | 0.48039729 |
| 88 | BRAF | 0.46852843 |
| 89 | LIMK1 | 0.46639684 |
| 90 | CAMK2D | 0.46577433 |
| 91 | MAP3K1 | 0.45068545 |
| 92 | MAP3K11 | 0.43610982 |
| 93 | MAP3K6 | 0.43163383 |
| 94 | ALK | 0.42976114 |
| 95 | PRKACA | 0.42343998 |
| 96 | FER | 0.42002407 |
| 97 | PDK1 | 0.41462000 |
| 98 | FGR | 0.41278173 |
| 99 | GRK7 | 0.41069809 |
| 100 | AKT3 | 0.40352486 |
| 101 | CSNK1D | 0.40170953 |
| 102 | MAP2K1 | 0.39781439 |
| 103 | FYN | 0.39094663 |
| 104 | RPS6KA3 | 0.39039455 |
| 105 | PINK1 | 0.38905794 |
| 106 | PDPK1 | 0.38081141 |
| 107 | PRKG1 | 0.36845472 |
| 108 | CAMK4 | 0.36221086 |
| 109 | CSNK1A1 | 0.35452110 |
| 110 | ADRBK1 | 0.35269354 |
| 111 | DYRK3 | 0.34061436 |
| 112 | DAPK3 | 0.33794771 |
| 113 | MAPK10 | 0.33574480 |
| 114 | MAPK12 | 0.32029390 |
| 115 | CSNK1E | 0.31357737 |
| 116 | PRKAA1 | 0.30525817 |
| 117 | PRKCA | 0.30280549 |
| 118 | MAP3K5 | 0.29437829 |
| 119 | PRKACB | 0.27711411 |
| 120 | ADRBK2 | 0.27209522 |
| 121 | PRKCB | 0.26714827 |
| 122 | MAPK9 | 0.26413411 |
| 123 | MAPK8 | 0.25432960 |
| 124 | MAPK4 | 0.24145003 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.89271075 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.65768420 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.81015308 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.70016786 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.69372412 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.66307107 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.60484773 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.54712472 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.50870746 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.46915666 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.36005924 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.28708393 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.00176300 |
| 14 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.99545284 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.93014589 |
| 16 | Cocaine addiction_Homo sapiens_hsa05030 | 1.91688341 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.87513623 |
| 18 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.86854829 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.86801230 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.75141590 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.74288042 |
| 22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.73800593 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.70847161 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.62558090 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.57371564 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.55449607 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.48801025 |
| 28 | Gap junction_Homo sapiens_hsa04540 | 1.44694498 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.40775486 |
| 30 | Axon guidance_Homo sapiens_hsa04360 | 1.34593210 |
| 31 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.30889313 |
| 32 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.24465223 |
| 33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.19536877 |
| 34 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.19205588 |
| 35 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.17883957 |
| 36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.15234937 |
| 37 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.13323510 |
| 38 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.07732561 |
| 39 | Glioma_Homo sapiens_hsa05214 | 1.06282063 |
| 40 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.04500837 |
| 41 | Melanogenesis_Homo sapiens_hsa04916 | 1.03087480 |
| 42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.02309872 |
| 43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95021992 |
| 44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.93196331 |
| 45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92860940 |
| 46 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.91875084 |
| 47 | Phototransduction_Homo sapiens_hsa04744 | 0.89623759 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.89149779 |
| 49 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.86643229 |
| 50 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79671428 |
| 51 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.78312260 |
| 52 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77635940 |
| 53 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.75262072 |
| 54 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70702961 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70229823 |
| 56 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.69523165 |
| 57 | Alzheimers disease_Homo sapiens_hsa05010 | 0.69070452 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68921436 |
| 59 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67824151 |
| 60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66865497 |
| 61 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66607024 |
| 62 | Alcoholism_Homo sapiens_hsa05034 | 0.66486019 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.66006871 |
| 64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.65992014 |
| 65 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.64178405 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60704920 |
| 67 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.59922489 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59358472 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59297845 |
| 70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57765986 |
| 71 | Parkinsons disease_Homo sapiens_hsa05012 | 0.57699158 |
| 72 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55951243 |
| 73 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55904321 |
| 74 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.55834070 |
| 75 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.53566515 |
| 76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.53545165 |
| 77 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52545325 |
| 78 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52536077 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51693341 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.51223735 |
| 81 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.51176847 |
| 82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50633339 |
| 83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.47374296 |
| 84 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46990651 |
| 85 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46643601 |
| 86 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44343154 |
| 87 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.43791018 |
| 88 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42164004 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.41986020 |
| 90 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.41632155 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41428728 |
| 92 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.40618356 |
| 93 | Colorectal cancer_Homo sapiens_hsa05210 | 0.40055793 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38019651 |
| 95 | Phagosome_Homo sapiens_hsa04145 | 0.36891073 |
| 96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.35766043 |
| 97 | Bile secretion_Homo sapiens_hsa04976 | 0.34679822 |
| 98 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.34158866 |
| 99 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.33807121 |
| 100 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33667424 |
| 101 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33352335 |
| 102 | Huntingtons disease_Homo sapiens_hsa05016 | 0.33277250 |
| 103 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.32613860 |
| 104 | Circadian rhythm_Homo sapiens_hsa04710 | 0.32453185 |
| 105 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32009299 |
| 106 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31476294 |
| 107 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.30500491 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28625391 |
| 109 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.28139638 |
| 110 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.27972680 |
| 111 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.26801644 |
| 112 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.25993504 |
| 113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.25553173 |
| 114 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.24997202 |
| 115 | Salmonella infection_Homo sapiens_hsa05132 | 0.24395313 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.23981049 |
| 117 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.23751670 |
| 118 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.23231721 |
| 119 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.22193623 |
| 120 | Tight junction_Homo sapiens_hsa04530 | 0.18630606 |

